Fragile X syndrome is the most common form of inherited intellectual disability, with no cure available. Individuals with the syndrome cannot produce enough of a protein—called the fragile X mental retardation protein (FMRP)—whose function has remained somewhat mysterious. Now researchers, reporting online April 17 in the Cell Press journal Molecular Cell, show that the FMRP protein regulates the machinery within a cell that is responsible for generating all functional proteins. The findings provide new insights into how Fragile X syndrome develops and could lead to novel therapies that might help restore some of the capabilities lost in affected individuals.
FMRP is highly expressed in the brain and is important for normal brain development. Previous studies have shown that FMRP regulates the expression of many proteins throughout the brain, and that in the absence of FMRP, ribosomes—the protein-synthesizing machinery of the cell—will translate some of the brain's genetic material into proteins in an inappropriate fashion, resulting in disease. However, the precise mechanism used by FMRP to regulate protein expression is unknown.
Fragile X Syndrome
Fragile X syndrome is an inherited X-linked genetic disorder that results in developmental and intellectual disabilities, along with behavioral problems.
"In this study, we clearly show that FMRP binds directly to the ribosome such that it would regulate its function," says Dr. Rajendra Agrawal, one of the senior authors and a principal investigator at the Wadsworth Center, New York State Department of Health and the State University of New York at Albany. "FMRP binds in between the two ribosomal subunits, overlapping with the binding position of various translational factors on the ribosome," he explains. Thus, when FMRP is bound to the ribosome, it influences the binding of other critical factors that attach to the ribosome and are important for the proper production of brain proteins.
Link Between Breast Cancer Progression and Fragile X Syndrome Protein Found
University of Rome Tor Vergata researcher Claudia Bagni has found a link between breast cancer progression and the Fragile X Mental Retardation Protein, or FMRP.
The findings could also provide insights into other conditions that may be caused by defects in translation of genetic information into proteins. "Similar to FMRP, it is possible that there are other proteins in the cell that bind directly to the ribosome as well to regulate gene expression," says senior author Dr. Simpson Joseph of the University of California at San Diego. "When these translational regulatory proteins are mutated, it may lead to disease."
Source: Eurekalert
Large Scale Screening of Fragile X Syndrome in Newborn Babies Possible
A new study reveals that the number of babies who carry the form of a gene FMR1 is higher than previously thought.
 Increasing Natural Marijuana-like Brain Chemicals Possible Treatment for Fragile X Syndrome SymptomsBoosting natural marijuana-like chemicals in the brain can help correct behavioral issues related to fragile X syndrome, the most common known genetic cause of autism. | Advertisement
|
Recommended Readings
Latest Research News
